These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10678549)

  • 1. Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hypertens; 2000 Jan; 18(1):97-101. PubMed ID: 10678549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does renal function improve after diagnosis of malignant phase hypertension?
    Lip GY; Beevers M; Beevers DG
    J Hypertens; 1997 Nov; 15(11):1309-15. PubMed ID: 9383181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and survival of 315 patients with malignant-phase hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hypertens; 1995 Aug; 13(8):915-24. PubMed ID: 8557970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs?
    Lip GY; Beevers M; Beevers DG
    Am J Hypertens; 2000 Aug; 13(8):934-9. PubMed ID: 10950403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception.
    Lip GY; Beevers M; Beevers DG
    QJM; 1997 Sep; 90(9):571-5. PubMed ID: 9349449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study.
    Shantsila A; Lane DA; Beevers DG; Lip GY
    J Hypertens; 2012 May; 30(5):974-9. PubMed ID: 22495136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hypertension in the elderly.
    Lip GY; Beevers M; Potter JF; Beevers DG
    QJM; 1995 Sep; 88(9):641-7. PubMed ID: 7583078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in renal function with percutaneous transluminal coronary angioplasty.
    Lip GY; Rathore VS; Katira R; Singh SP; Watson RD
    Int J Cardiol; 1999 Jul; 70(2):127-31. PubMed ID: 10454300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
    Roussos L; Christensson A; Thompson O
    Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project.
    Shantsila A; Lane DA; Beevers DG; Lip GY
    Hypertens Res; 2013 Jun; 36(6):546-9. PubMed ID: 23407241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis in malignant or accelerated hypertension.
    Guerin C; Gonthier R; Berthoux FC
    Nephrol Dial Transplant; 1988; 3(1):33-7. PubMed ID: 3132637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hypertension in patients with idiopathic IgA nephropathy.
    Chen Y; Tang Z; Yang G; Shen S; Yu Y; Zeng C; Chen H; Liu ZH; Li LS
    Kidney Blood Press Res; 2005; 28(4):251-8. PubMed ID: 16340218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microangiopathic hemolysis and renal failure in malignant hypertension.
    van den Born BJ; Honnebier UP; Koopmans RP; van Montfrans GA
    Hypertension; 2005 Feb; 45(2):246-51. PubMed ID: 15596574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study.
    MacWalter RS; Wong SY; Wong KY; Stewart G; Fraser CG; Fraser HW; Ersoy Y; Ogston SA; Chen R
    Stroke; 2002 Jun; 33(6):1630-5. PubMed ID: 12053003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in malignant hypertension selected by multivariate analysis.
    Guerin C; Berthoux F
    Nephrol Dial Transplant; 1990; 5(8):563-8. PubMed ID: 23275987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project.
    Shantsila A; Dwivedi G; Shantsila E; Steeds RP; Beevers G; Lip GY
    Hypertens Res; 2012 Jul; 35(7):725-8. PubMed ID: 22357519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.